Brevitest Technologies, Inc.
Biotechnology company · Houston, Texas, United States
Brevitest Technologies, Inc. is a biotechnology company headquartered in Houston, Texas, United States. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $2.2 million in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2021.
Brevitest Technologies at a glance
What does Brevitest Technologies do?
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $2.2 million in total (2016 to 2019). NIH funding came from the National Institute on Drug Abuse, National Institute on Minority Health and Health Disparities.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $2.7 million sold (2021).
Frequently asked questions about Brevitest Technologies
Where is Brevitest Technologies headquartered?
Brevitest Technologies, Inc. is headquartered in Houston, Texas, United States.
What does Brevitest Technologies do?
Brevitest Technologies, Inc. is a biotechnology company.
Similar companies
- Pulmotect, Inc.Houston, Texas, United States
- Kiromic Biopharma, Inc.Houston, Texas, United States
- March Biosciences, Inc.Houston, Texas, United States
- Autoimmunity Biologic Solutions Inc.Houston, Texas, United States
- Fannin Partners, LLCHouston, Texas, United States
- Pupil Bio, Inc.Houston, Texas, United States
- Asylia Therapeutics, Inc.Houston, Texas, United States
- Procyrion, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences